Mirum Pharmaceuticals (MIRM) announced the appointment of Doug Sheehy as Chief Legal Officer. Sheehy was most recently Chief Legal Officer at Sonoma Biotherapeutics. He brings nearly two decades of experience leading global legal and compliance operations for biopharmaceutical companies.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MIRM:
- Mirum Pharmaceuticals assumed with a Buy at H.C. Wainwright
- Mirum Pharmaceuticals price target raised to $77 from $73 at Raymond James
- Buy Rating on Mirum Pharmaceuticals: Promising Phase 2b VANTAGE Study Results and Strong Market Potential
- Mirum’s volixibat shows ‘best-in-class potential,’ says Citi
- Mirum Pharmaceuticals price target raised to $76 from $74 at Citizens JMP